We are live on ! Find out more
RCI

Ridgeback Capital Investments Portfolio holdings

AUM $560K
This Fund
S&P 500
This Quarter Est. Return
+12.29%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$23.2M
AUM Growth
–
Cap. Flow
+$22.9M
Cap. Flow %
98.33%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TVRD
Tvardi Therapeutics
TVRD
+$9.49M
2
TRIL
Trillium Therapeutics Inc.
TRIL
+$5.15M
3
ONCS
OncoSec Medical Incorporated
ONCS
+$4.42M
4
AGTC
Applied Genetic Technologies Corporation
AGTC
+$3.79M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVRD
1
Tvardi Therapeutics
TVRD
$23.6M
$10.5M 45.13%
+17,282
New +$9.49M
AGTC
2
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5.02M 21.59%
+246,005
New +$3.79M
TRIL
3
DELISTED
Trillium Therapeutics Inc.
TRIL
$4.67M 20.1%
+370,537
New +$5.15M
ONCS
4
DELISTED
OncoSec Medical Incorporated
ONCS
$3.06M 13.18%
+5,876
New +$4.42M

Similar funds

LPARFS
Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54K AUM
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return
ZIMP
Zimmermann Investment Management & Planning New Cumberland, Pennsylvania $2.27M AUM 29.81% 1-Year Est. Return
XS
XR Securities Chicago, Illinois $5.35M AUM 26.1% 1-Year Est. Return
B
Braslyn New Providence, Bahamas $7.81M AUM 338.68% 1-Year Est. Return
AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Ridgeback Capital Investments's Q4 2015 Portfolio in Review

Q4 2015 is the first quarter with a 13F filing on record for Ridgeback Capital Investments, which disclosed 4 positions worth $23.2M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Tvardi Therapeutics: 17,282 shares worth $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets.

  • Ridgeback Capital Investments's largest Q4 2015 buy was Tvardi Therapeutics: 17,282 shares worth $10.5M.
  • Ridgeback Capital Investments's ten largest holdings make up 100% of its $23.2M portfolio in Q4 2015.
  • Ridgeback Capital Investments disclosed 4 positions in Q4 2015, its first 13F filing on record.

Based on Ridgeback Capital Investments's 13F filing for Q4 2015, filed 16 Feb 2016.